Startup | August 25, 2021
Regimen launches world’s first personalised digital therapy for ED
The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe
The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe
The agreement is to develop, manufacture and commercialise biosimilars for the global market.
Trillium’s portfolio includes biologics that are designed to enhance the ability of patients’ innate immune system to detect and destroy cancer cells
BD worked with JCI to create a Gold Standard benchmarked safety program called Preventing Risks of Infections and Medication Errors in IV Therapy (PRIME)
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
Substantial reduction in losses
Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030
This robust performance is a testimony of the company's agility, resilience and strong execution capabilities during these difficult times
A veteran in cell therapy and oncology commercialisation
Subscribe To Our Newsletter & Stay Updated
